第58回日本小児循環器学会総会・学術集会
2022年7月21日〜7月23日札幌コンベンションセンター
第58回日本小児循環器学会総会・学術集会
2022年7月21日〜7月23日札幌コンベンションセンター
[III-TSPCJS-01]Neurodevelopment outcome of children with congenital heart disease
○Shuenn-Nan Chiu(Pediatrics, National Taiwan University Hospital)
Children with CHD are at high risk for developmental delay and impairment. The impact of CHD on neurodevelopment is multifactorial including genetic, fetal, pre-operative, perioperative and post-operative factors. Some risk factors cannot be altered, but many risk factors are modifiable. Children with CHD may experience a delay across the spectrum of developmental domains.
AHA recommend routine surveillance, screening and evaluation for high risks population with the goal of early identification and intervention for neuro-developmental delays. Cardiac neurodevelopmental follow-up program through a multidisciplinary approach is the key to improving the outcome in children with CHD in the 21st century.
AHA recommend routine surveillance, screening and evaluation for high risks population with the goal of early identification and intervention for neuro-developmental delays. Cardiac neurodevelopmental follow-up program through a multidisciplinary approach is the key to improving the outcome in children with CHD in the 21st century.